|
|
| | Tafenoquine-d3 Succinate Basic information |
| Product Name: | Tafenoquine-d3 Succinate | | Synonyms: | Tafenoquine-d3 Succinate;trideuerium-labeled Tafenoquine derivative;WR-238605, WR 238605, WR238605, Tafenoquine;WR-238605, WR 238605, WR238605, TAFENOQUINE; TRIDEUERIUM-LABELED TAFENOQUINE DERIVATIVE; TAFENOQUINE-D3 SUCCINATE | | CAS: | 1133378-83-2 | | MF: | C28H34F3N3O7 | | MW: | 581.5806696 | | EINECS: | | | Product Categories: | Inhibitors & Agonists | | Mol File: | 1133378-83-2.mol |  |
| | Tafenoquine-d3 Succinate Chemical Properties |
| | Tafenoquine-d3 Succinate Usage And Synthesis |
| Uses | Tafenoquine-d3 Succinate is the labelled analog of Tatenoquine (T004760), a new 8-aminoquinoline with an improved therapeutic index and safety profile as compared to primaquine (P733500).Tafenoquine has the potential to become a widely used drug in the prevention and treatment of malaria infection and could replace some currently used drugs as resistant strains of Plasmodium species increase. |
| | Tafenoquine-d3 Succinate Preparation Products And Raw materials |
|